Your organization is committed to comply with ISO IDMP, as failure to comply could result in penalties up to max. five percent of the total revenue.However, there are still uncertainties pertaining to the scope and impact of implementation of ISO IDMP.This challenges organizations as executives ask what is the likely financial impact of ISO IDMP.
NNIT works with clients to solve the problem of estimating the likely financial impact of ISO IDMP. We combine industry experience and deep subject matter expertise to deliver solid advisory services to international pharmaceutical companies.As one of the official reviewers of the ISO IDMP implementation guides, NNIT has leading industry experience and subject matter expertise. This experience benefits our clients when estimating the impact of an ISO IDMP implementation program.
In NNIT’s experience, the company must consider whether IDMP is a compliance project or a benefit project. There are significant long-term business benefits to be realized, although driven by a short compliance objective. ISO IDMP will significantly change the way pharmaceutical companies operate.
Our approach includes a series of workshops that aims at raising awareness and creating alignment across the organization. The approach is adapted to fit client needs and can be executed within two to three weeks. NNIT has successfully delivered ISO IDMP business cases which cover: